🇺🇸 FDA

Intelligence · Patent portfolio

Takeda Patents

Full USPTO pharma patent portfolio for Takeda — grant dates, expiration, and drug cross-links.

Patents
1,436
Expiring ≤24m
81

Quick answer

Takeda has 1,436 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 81 expire within 24 months — use filters for patent-cliff planning.

Page 20 of 30

  1. US 8071130

    Solid preparation

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8067030

    Controlled release composition and method of producing the same

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8067453

    Neurotrophin production/secretion promoting agent

    Expires Mon Nov 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8063066

    MAPK/ERK kinase inhibitors

    Expires Mon Nov 17 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8058280

    Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8057990

    Screening method

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8048909

    Proton pump inhibitors

    Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8044049

    Fused heterocyclic derivative and use thereof

    Expires Mon Oct 20 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8039500

    Fused heterocyclic compounds

    Expires Mon Oct 13 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8034812

    Imidazopyridazine derivative having kinase inhibitory activity and pharmaceutical agent thereof

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8034822

    Glucokinase activators

    Expires Mon Oct 06 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8030333

    Benzimidazole compound crystal

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8030337

    Tricyclic compound and pharmaceutical use thereof

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8030317

    MAPK/ERK kinase inhibitors

    Expires Mon Sep 29 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8026234

    Polo-like kinase inhibitors

    Expires Mon Sep 22 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8022057

    MAPK/ERK kinase inhibitors

    Expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8013008

    Cyclic amine compound

    Expires Mon Sep 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8008525

    Receptor function regulating agent

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8008332

    Substituted indazoles as glucokinase activators

    Expires Mon Aug 25 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8003785

    Halo-substituted pyrimidodiazepines

    Expires Mon Aug 18 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 7998684

    Screening method for an agent for treatment of neurodegenerative disease

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 7998968

    Substituted pyrimidines and [1,2, 4] triazoles and the use thereof for treating prophylaxis, cardiovascular diseases, metabolic diseases and/or central nervous system diseases

    Expires Mon Aug 11 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 7994332

    Process for producing crystal

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 7994205

    Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 7994183

    Solid preparation comprising 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-4-fluorobenzonitrile

    Expires Mon Aug 04 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 7989445

    Thienopyrimidone compound

    Expires Mon Jul 28 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 7985863

    Iminopyridine derivatives and uses thereof

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 7985862

    Iminopyridine derivatives and use thereof

    Expires Mon Jul 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7981598

    Preventive/remedy for respiratory diseases

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7982044

    Iminopyridine derivatives and use thereof

    Expires Mon Jul 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7976853

    Process for producing coated preparation

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7973163

    Fused quinoline derivative and use thereof

    Expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7960416

    Stable emulsion composition

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7960369

    Receptor function regulator

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7960348

    Metastin derivatives and use thereof

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7960384

    Dipeptidyl peptidase inhibitors

    Expires Mon Jun 09 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 7951548

    IL-13 production inhibitor

    Expires Mon May 26 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  39. US 7943626

    Substituted 1,3-dialkyl-2,4-dioxo-6-(pyridylamino)-1,2,3,4-tetrahydropyrimidine-5-hydroxamic acid inhibitors of MAPK/ERK kinase

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  40. US 7943659

    MAPK/ERK kinase inhibitors

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  41. US 7943770

    Fused quinoline derivative and use thereof

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  42. US 7943137

    FPRL1 ligands and use thereof

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  43. US 7943580

    Polypeptide and the use thereof

    Expires Mon May 12 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  44. US 7932289

    Remedy for diabetes

    Expires Mon Apr 21 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  45. US 7928105

    Substituted 6a,7,8,9-tetrahydropyrido[3,2-e]pyrrolo[1,2-a]pyrazin-6(5H)-ones

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  46. US 7927821

    Methods of screening for compounds which bind G protein-coupled receptors

    Expires Mon Apr 14 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  47. US 7919260

    Screening methods using GPR52

    Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  48. US 7915267

    Heterocyclic amide compound and use thereof

    Expires Mon Mar 24 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Takeda have?

1,436 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

81 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Where does this data come from?

USPTO PatentsView bulk data filtered to pharmaceutical CPC classes (A61K, A61P), cross-linked to NovaPharmaNews company and drug profiles. See our data sources page for methodology.

Data attribution: Data sources · Patent directory

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.